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Background: To establish a common database on particle therapy for the evaluation of clinical studies integrating
a large variety of voluminous datasets, different documentation styles, and various information systems, especially in
the field of radiation oncology.
Methods: We developed a web-based documentation system for transnational and multicenter clinical studies in
particle therapy. 560 patients have been treated from November 2009 to September 2011. Protons, carbon ions or
a combination of both, as well as a combination with photons were applied. To date, 12 studies have been
initiated and more are in preparation.
Results: It is possible to immediately access all patient information and exchange, store, process, and visualize text
data, any DICOM images and multimedia data. Accessing the system and submitting clinical data is possible for
internal and external users. Integrated into the hospital environment, data is imported both manually and
automatically. Security and privacy protection as well as data validation and verification are ensured. Studies can be
designed to fit individual needs.
Conclusions: The described database provides a basis for documentation of large patient groups with specific and
specialized questions to be answered. Having recently begun electronic documentation, it has become apparent
that the benefits lie in the user-friendly and timely workflow for documentation. The ultimate goal is a
simplification of research work, better study analyses quality and eventually, the improvement of treatment
concepts by evaluating the effectiveness of particle therapy.
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Particle therapy as an innovative and relatively new tech-
nique is of increasing interest in radiation oncology.
Compared to standard radiation therapy (RT) with
photons, the main advantages lie in the distinct physical
characteristics of particles enabling a more precise dose
delivery to the target and thereby sparing of normal tis-
sue and organs at risk [1,2]. Heavier ions, such as carbon
ions, additionally offer distinct biological characteristics* Correspondence: stephanie.combs@med.uni-heidelberg.de
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reproduction in any medium, provided the orleading to an increase in relative biological effectiveness
(RBE) [3]: for example, it has been shown, that for glio-
blastoma cell lines, the RBE lies between 3 and 5 de-
pending on cell type and endpoint [4].
For several further indications, clinical results of particle
therapy have been shown to be beneficial [5,6]. Particle
therapy, however, has been available only in a limited
number of institutions. While proton therapy is more
widespread, especially in the United States, carbon ion
radiotherapy was only available in Japan and Germany.
Beginning in 1997, treatment was performed at the Gesell-
schaft für Schwerionenforschung (GSI) in Darmstadt,
Germany and since November 2009, treatment has becometd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Therapy Center (HIT) in Heidelberg, Germany. In the near
future, other European Centers will take up clinical oper-
ation. Recently, the CNAO (National Centre for Onco-
logical Hadrontherapy) in Pavia, Italy, started patient
treatment with particle therapy.
Since several European particle therapy initiatives are
underway, and since clinical data, especially with respect
to randomized clinical studies, still remains scarce [7],
the logical consequence is to combine all efforts in the
field of particle therapy and to generate a common plat-
form for all patients treated with particle beams. There-
fore, within the transnational access (TNA) pillar of the
ULICE project (Union of Light Ions Centers in Europe)
funded by the European Commission, the generation of
a common database has been a main focus.
Researchers at the HIT started developing this com-
mon database and documentation system to conduct
international, multicenter clinical studies where all pa-
tient data is gathered by the participating institutions.
During this process, increasingly large amounts of pa-
tient data must be analyzed. In general, analyzing clinical
studies, in particular retrospectively, which contain large
patient groups, is rather difficult, because of size and
heterogeneity of the data and the different documenta-
tion style within different departments. Especially radi-
ation oncology as an interdisciplinary field must deal
with a large variety of voluminous datasets from various
information systems. This demands special coordination
in data management. Therefore, we primarily need a
documentation and management system integrated in
the clinical environment, but preferably an additional,
built-in possibility for immediate analysis of the col-
lected data.
Nowadays, in the age of modern technology, the first
choice exists in using Internet technologies for trans-
national access. It is easiest and most common to work
together by using the web. It has not only the advantage
of having a high user acceptance and intuitive usability,
but also to be platform-independent. Especially in health-
care, it is crucial to have all patient information on hand
- even on mobile devices [8] - particularly in radiotherapy
where one is always involved with imaging information.
In this paper, we describe our approach and first steps
to achieving an international web-based documentation
system in particle therapy. Our main aim is to transfer
results and experiences with treatment concepts and
ideas to potential new ion centers about to be set up
worldwide.
Methods
General database concept
The database is constructed to assemble clinical, bio-
logical, and physical data of all patients treated withparticle therapy within the ULICE framework. To valid-
ate and establish the workflow in the database system, at
first patients treated at the leading TNA institution HIT,
have been included.
From November 2009 to September 2011 560 patients
received treatment at the HIT. Protons (H1), carbon ions
(C12) or a combination of both, as well as a combination
with photons were applied to the target with the intensity-
modulated rasterscanning technique [1,9,10]. When the
center is fully operational, about 1300 patients will be trea-
ted every year using two treatment rooms with simple
horizontal beam control and one with a gantry providing
the opportunity for a 360° beam direction.
The next step will be to allow patients treated in the
other particle therapy centers, firstly CNAO in Pavia, Italy,
to also be documented in the database system. Using web-
based access, referring physician and co-researchers
within the ULICE project can access “their” data and pro-
vide additional information as well as follow-up data.
The system will offer the unique possibility to docu-
ment specific clinical protocols or rather, studies, as
summarized in Table 1.
3-Phase plan to attain a common database
It is still not unusual for clinical study documentation to
be achieved with collections of paper-based case report
forms (CRFs), excel sheets and local copies of medical
images. It is not necessary to explain the disadvantages of
such unstructured and distributed documentation. The
main goal of our approach is to provide a central, web-
based database and documentation system, with interfaces
to the main existing information systems of the hospital
for data import, to avoid double entries of patient and
clinical data wherever possible.
To accomplish this goal, we designed a 3-phase plan.
Phase 1 consists of an overall analysis of the patient work-
flow during a radiation therapy at the HIT; choosing a
basic documentation system, which can be easily adapted
and altered as necessary; and designing and implementing
the basic modules for overall documentation.
The main part of the second phase is to connect the
mandatory information systems of the hospital and the
implementation of HL7 and DICOM interfaces for data
import. The main input consists of overall treatment
and follow-up data, physical data such as treatment
plans, total dose and dose distribution as well as bio-
logical, molecular and pathological information. Security
and data protection measures are implemented to fulfill
legal requirements. Furthermore, the first specific clin-
ical studies are designed and generated.
In phase 3, all existing clinical studies, particularly mul-
ticenter studies, are included in the database system.
Therefore, the web-based access as an international plat-
form for joint clinical research will be realized. In addition,
Table 1 Studies being initiated at the Heidelberg Ion Therapy center (HIT)
Study Indication Treatment concept
CLEOPATRA Primary glioblastoma H1 vs. C12 Boost
CINDERELLA Recurrent or progressive glioma C12 vs. standard therapy
CHONDROSARCOMA Skull base chondrosarcoma H1 vs. C12
CHORDOMA Skull base chordoma H1 vs. C12
MARCIE Atypical meningioma grad 3 and 4 C12 Boost
COSMIC Salivary gland tumor C12 Boost
ACCEPT Adenoid cystic carcinoma C12 Boost
PROMETHEUS Hepatocellular carcinoma C12
OSCAR Inoperable osteosarcoma H1+C12
IPI Prostate carcinoma C12 Boost
PANDORA Rectal carcinoma C12
TPF Head-neck tumor C12 Boost
PHOENIX-01 Pancreatic cancer C12
PINOCCHIO Low-Grade meningioma Photon vs. H1 vs. C12
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siring to use this new technology for their patients are able
to request particle therapy and receive assistance with or-
ganizing complex treatment sequences.
Naturally, it is necessary to be able to follow the
course of treatment at all times in order to provide opti-
mal patient care [11]. Especially for external patients,
knowledge of previous treatment is vital for the respon-
sible oncologist in order to plan ion radiation. Therefore,
all data for evaluating the case must be uploaded.
Understandably, the referring physician himself is inter-
ested in the progress of treatment, while both parties
will be awaiting the follow-up results.
Results
After a period of eight months, we completed phase 1 in
May of 2010 and are now intensively working on phase
2. We plan to start phase 3 in early 2012 and finish the
project by the end of 2013. Electronic documentation
was started in May 2011, and all patients are being
documented. The following sections describe our results
from the first two phases and the current progress.
General principles and architecture
The basis of the documentation system is built with an
open source PostgreSQL database with standard inter-
faces to the PACS world. It is based on the DICOM data
model and can be dynamically extended with additional
data structures. Interfaces allow the exchange and
process of DICOM data as well as other information via
HL7 messages.
A telemedicine record [12] functioning as an extension
is added with the characteristic of an electronic patient
record (EPR) and a professional DICOM viewer (ClassIIb; according the European Medical Devices Directive).
It allows the user to exchange, store, process, and
visualize text data, all types of DICOM images and other
multimedia data.
This general infrastructure was originally developed by
the CHILI GmbH, a company specialized in radiology
systems with whom we are privileged to maintain a
strong cooperation and to whom we attribute the tech-
nical know-how and experience [13]. Based on our vi-
sion for the ULICE project, we have planned and
implemented additional functionality and customized
the general setting, thus creating a specialized study
documentation system.Data presentation and storage
On the one hand, data can be imported to the system
automatically via the mentioned standard DICOM and
HL7 interfaces. On the other hand, the user can import
it manually. This is done by entering single values into
the interactive documentation modules or by web-
upload of any multimedia documents through an inter-
face, which has been implemented as a Java applet
running in any Internet browser. Furthermore, a long-
term archive (6 TB) is available to store and backup all
DICOM, multimedia and documentation data.
The web-based graphical user interface is independent
both from the running operation system (e.g. MAC OS,
Linux, MS-Windows) and the used browser (e.g. Safari,
Mozilla, Internet Explorer). Presentation and access to
patient information is always patient-oriented. First, after
logging in, the system shows the list of all patients
included in that particular study, for whom the user is
authorized. The data shown in the list can be configured
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sorted and filtered individually.
After selecting one patient record, basic patient informa-
tion is shown in the header as well as the created module
entries for this patient. Figure 1 shows the view of a single
patient with integrated radiation information. With a click
on an imaging thumbnail, the DICOM-RT viewer is
opened displaying the corresponding examination (see
Figure 2 and Figure 3). This viewer is also web-based, can
be executed from every workstation in the hospital, and
will even be available for external users. Currently, we are
developing the extension for visualizing the dose distribu-
tion and dose-volume histogram (DVH).
Workflow integration
The system is connected with the Hospital Information
System (HIS), the Laboratory Information System (LIS),
the Picture Archiving and Communication Systems
(PACS) and the Oncology Information System (OIS) in
order to acquire automatic input via HL7 messages and
DICOM (see Figure 4). Interfaces to the HIS provide the
initial setting of patients with HL7-ADT messages. La-
boratory findings such as blood results are automaticallyFigure 1 Screenshot showing a patient record with radiation informaimported via HL7-ORU messages from the LIS, and inter-
faces to the PACS reveal radiation data by DICOM RT
and DICOM RT ion (e.g. DICOM RT image/structure set/
plan/dose/treatment record, CT and MR imaging). The
OIS supplies further radiation information such as first
and last day of irradiation, radiation method, and the ap-
plied particle-type over HL7-DFT messages. These mes-
sages are also used to trigger a DICOM Q/R (Query/
Retrieve) on the different PACS to automatically import
radiation data into the documentation system and map it
to the corresponding patient (see Figure 1).
One external user is, for example, a referring physician
possibly from a collaborating partner from abroad. He
can upload all existing imaging information and detailed
treatment data (e.g. surgery findings, blood results) from
the patient’s previous treatments into the documentation
system over the Internet. The physician at the HIT will
review the case and decide if an indication for particle
therapy is given and possibly a study inclusion. If the pa-
tient is accepted for an irradiation in Heidelberg, all fur-
ther essential data is documented in the system. After
the particle therapy, the referring physician continues
the common documentation during the follow-up periodtion linked to the study documentation.
Figure 2 Screenshot of our web-based DICOM-RT viewer showing the ROIs of a radiation plan in the transversal (top left), coronal
(bottom left) and sagittal (bottom right) layers. The corresponding colors are listed at the top right.
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are not connected, there is always the possibility for
manual upload for DICOM or any other multimedia
data.
Security concept
Since the system is used in a clinical environment, spe-
cific privacy and security mechanisms are required. The
system uses the https protocol to exchange data between
the central server and other systems (see Figure 4). This
enables an encrypted data transfer.
Users need an account and password to access the sys-
tem. A roles-and-rights concept has been established to
configure access to each study of the system separately.
So far, we created the main roles: physician (level 1, level
2), study nurse / case manager, physicist, simple user
(e.g. student) and admin. Additionally, we can merge users
into user groups, for example, all users from a specific
institution. The roles of a user can change dynamicallyand are study-dependent, i.e. being a leading physician
(level 1) for one study, and for another a standard user
with only reading rights.
Furthermore, all data can be pseudonymized by a PID-
Generator by the TMF (Technology, Methods, and In-
frastructure for Networked Medical Research) [14],
when it is imported into the system. The original patient
information is then kept in a separate database. When a
user has the right to view all data of a patient, the data
is de-pseudonymized instantaneously - but only for the
specific user. One user is typically the treating physician
with full access to all data. Other users, e.g. researchers
or external physicians, only have restricted access to
pseudonymized data.
Communication with external users from participating
study centers is realized by an intermediate application
gateway in the demilitarized zone (DMZ) which receives
https-requests, checks them and sends only valid
requests to the server in the intranet of the hospital (see
Figure 3 Screenshot of our web-based DICOM-RT viewer showing the dose distribution of a radiation plan in the transversal (top left),
coronal (bottom left) and sagittal (bottom right) layers. The corresponding colors are listed at the top right.
Figure 4 Connected systems and used protocols.
Kessel et al. Radiation Oncology 2012, 7:115 Page 6 of 9
http://www.ro-journal.com/content/7/1/115
Kessel et al. Radiation Oncology 2012, 7:115 Page 7 of 9
http://www.ro-journal.com/content/7/1/115Figure 4). Additionally, client certificates are used to
provide more host-to-host security and to verify author-
ized browsers of external project partners.
Study and module design
In principle, each clinical study is designed and adminis-
tered separately, consisting of several single modules.
However, once a module is designed, it can be reused
again. To this end, the documentation system has a
graphical advanced administration tool, which includes a
form generator for designing and adjusting specific mod-
ules for the individual clinical studies. It covers both the
generation of the data structures and the corresponding
graphical user interface. A major advantage is that this
tool can be used by the local system administrators and
does not need new developments by computer experts.
Aside from that, a test system has been set up where
new modules can be created, validated, and tested before
they are used in the productive environment.
Very early, we decided not only to document patients
treated within specific focused study protocols, but also
patients not participating in clinical studies (non-study
patients), meaning all patients ever treated with particle
therapy, because, of course, not every patient fulfills the in-
clusion and exclusion criteria of a particular study. Thus, a
default study is available where all patients are documented
initially, until it is decided that they take part in a clinical
study. In that case, a patient can be assigned to the study
accordingly within the documentation system.
This can only be achieved by similar basic documenta-
tion for each type of patient (study or non-study) and led
us to develop three different kinds of modules. Table 2
summarizes all existing modules. Basic modules are used
for all patients and include vital patient information. The
module for the treatment overview contains information
such as diagnosis (ICD-O), TNM classification, tumorTable 2 Documentation modules divided into basic
modules and modules for non-study and study patients
Basic modules Non-study modules Study modules
Basic patient data Region module Screening
Treatment overview Head / neck Inclusion / exclusion
criteria
Case management Brain / skull base Pre-study treatment
RT images Upper GI Study treatment
RT documentation Lower GI Last examination
Spine Follow-up
Pelvis AE (Adverse Event)
Extremities SAE (Serious
Adverse Event)
Recurrence /metastasis
Death
The study modules are tailored to fit the CLEOPATRA study.region and planned radiation therapy as well as previous
oncological therapies. Radiation data, such as DICOM-RT,
CTs and MRIs are stored in the RT images module; the
corresponding precise details (e.g. dose information, num-
ber of fields, time and organs at risk) are mapped into the
RT documentation module. The case management mod-
ule is used for organizational data management, i.e. the
health insurance, payment status, etc.
For non-study patients, depending on the location of
the tumor region, a specific region module must be used
for documentation during screening, treatment and
follow-up periods. These modules contain information
that is again similar for all region types, for example kar-
nofsky index, acquisition date of imaging, tumor diam-
eter and response. However, corresponding symptoms
and side-effects are documented individually. The recur-
rence / metastasis module documents the location and
treatment method of the recurrence / metastasis; the
death module the date and cause of death.
Furthermore, each clinical study has its own modules
specifically designed to document the parameters that
are required by the study protocol and / or CRF.
Usability
Clinical documentation and analyses are crucial for an op-
timal patient care and medical research. However, this is
not a particularly popular task. For this reason, we aim to
replace manual input with automatic documentation wher-
ever possible. Several features are implemented to support
the documentation process and prevent double entries pa-
tient information. Certain modules are only selectable if
predefined conditions are fulfilled. Some modules are only
selectable once for each patient or depending on a previ-
ously created file entry. So-called listeners are implemented
to fill data fields automatically, such as the time interval
between surgery and the particular day or the age at study
entry. Links to existing file entries within the documenta-
tion system help to switch between corresponding infor-
mation. A patient-related link accessing the HIS from the
documentation system makes it easy to search for add-
itional patient information that is not part of the documen-
tation system. Furthermore, a web-based ICD-O selector is
implemented as an add-on feature for a standard docu-
mentation of diagnoses only allowing the search and inser-
tion of valid encodings. We added a consultation feature
for physicians to review findings or to obtain a second
opinion. With the lock-option, a module-entry, a group of
entries or even a whole case can be locked and thereafter
not changed again by anyone. This is relevant for monitor-
ing studies.
Analyses
This task is still work in progress. Presently, data entries
from the database can be exported as an Excel sheet. Thus,
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related questions within seconds - always up-to-date with
the current status of information. To allow this, a query
builder has been implemented, which supports the user to
generate individual queries very intuitively. Additionally,
these can be saved and reused any time for a continuous
overview on the data. Case managers are using this func-
tionality to monitor upcoming patient visits and to ensure
complete and correct documentation.
Discussion
The present manuscript describes the generation of a
common European database and documentation system
on particle therapy developed within the ULICE project.
The goal is to summarize all biological, physical, and clin-
ical data in one European system to generate a broad data-
set on particle therapy. Hence, new treatment standards
will be developed and tested on the basis of further clinical
studies within ULICE. Each study can be designed and
adjusted as needed within the system. By documentation
of all patients ever treated with particle therapy, we can
evaluate single studies prospectively and gain the possibil-
ity for overall large-scale, retrospective studies.
Different information systems such as the HIS, OIS
and PACS have been connected successfully, allowing
documentation and evaluation of different analyses.
All access to the documentation system takes place via
the web. Thus, no software needs to be installed on clin-
ical computers, as a web-browser is standard, and there-
fore the system can be immediately accessed everywhere
on the Internet. The only prerequisite is an installed Java
Runtime Environment (JRE). The web-based approach
with its strong security measures allows the usage of the
system for multicenter studies within the ULICE project
and enables the essential patient referral functionality.
Moreover, this will play a crucial role for the follow-up
documentation. With the web-based access we can dir-
ectly receive outcome reports by the physicians and even
patient-reported-outcome reports according to the
protocol, assessed in the vicinity of the patient’s home.
The usage of the documentation system is very simple
and user-friendly as proven by first feedback from study
nurses, case managers and physicians. The interactive docu-
mentation modules with their many features prevent wrong
data input and guarantee data validation and verification.
In the environment of radiotherapy, it is essential that
any DICOM RT data can be processed and visualized by
all systems. Processing and display of RT data today is
not yet a standard functionality of PACS or teleradiology
systems. However, our system is able to exchange and
store all kinds of DICOM RT data. The innovative, inte-
grated and web-based DICOM viewer ensures examin-
ation of radiation plans from every single computer in
the hospital. This enables physicians to quickly reviewimages without having to go to a PACS or even a radi-
ation therapy planning station.
Many others have already said there is no “one-size-
fits-all” solution for web-based documentation of clinical
studies or patient data per se [15]. The large number of
requirements and circumstances for the system make an
individual approach necessary. Our solution differs from
other systems, which either only manage and organize
patient treatment within a single department [16,17] or
other numerous approaches only focused on electronic-
ally documenting a single clinical study [18-21]. We
combine both. On the one hand, we developed a com-
mon platform that allows us to coordinate clinical stud-
ies in radiation oncology even across departments, and
on the other hand, we linked it all to the mandatory in-
formation systems to manage a complete treatment
overview with more detailed information that might be
proven to be relevant in retrospect.
Conclusion
The major benefit of this system lies in the fact that im-
aging information, i.e. RT, CT and MRI data is directly
linked to the rest of the study, or rather treatment docu-
mentation (see Figure 1) and can be simply and quickly
accessed with standard web-browsers. This, in turn, sim-
plifies the process of conducting multicenter studies dis-
tributed all over Europe. It gives us the opportunity to
extend the analysis functionality to a more complex
level. With the main aim to reduce the effort for future
clinical studies, we are planning a separate functionality
for prospective and retrospective data analyses. It will
not only be able to answer simple statistical questions,
but also considering imaging information. MR imaging
and dose distribution are to be compared before and
after treatment and thus reveal their direct correlation
with clinical endpoints (e.g. overall survival, disease-free
survival, recurrence location).
In conclusion, the documentation system of today sim-
plifies the research work, ensures a better quality of
study analyses, and ultimately improves patient treat-
ment concepts and supports the evaluation of the role
and effectiveness of particle therapy.
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